28th August 2019 / Sciad Newswire / Amyndas Pharmaceuticals, a clinical-stage biopharmaceutical company focused on the devel
August 2019
Wed, 28/08/2019 - 09:50
Tue, 13/08/2019 - 09:00
Synpromics to operate as a wholly owned subsidiary; the two companies bring together pioneering technology to increase efficacy of gene therapeutics